Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution

The new digital platform aims to improve patient experience and outcomes for injectable drug delivery.

Apr. 8, 2026 at 9:38pm

Got story updates? Submit your updates here. ›

An abstract, ghostly X-ray image revealing the internal components of a wearable drug delivery device, conceptually representing the integration of digital technology and innovative medical technology.The new digital platform will integrate with Enable's innovative on-body injector to provide patients with real-time data, insights, and personalized support.Crystal Lake Today

Aptar Digital Health, a division of global packaging and drug delivery solutions provider Aptar, has announced a partnership with Enable Injections, a leader in wearable drug delivery devices, to develop a new companion digital platform for Enable's enFuse® on-body injector. The platform will provide patients with real-time data, insights, and support to enhance the user experience and improve medication adherence.

Why it matters

The collaboration between Aptar Digital Health and Enable Injections brings together expertise in digital health technologies and innovative drug delivery devices. This partnership aims to address key challenges in injectable medication management, such as improving patient engagement, tracking usage data, and providing personalized support to enhance the overall treatment experience.

The details

The new digital platform will integrate with Enable's enFuse® on-body injector, allowing patients to access real-time data, educational resources, and support features through a mobile app or web portal. This includes tracking injection progress, receiving medication reminders, and accessing personalized coaching to help manage their condition. The platform will also provide healthcare providers with valuable usage data and insights to optimize patient care.

  • The partnership between Aptar Digital Health and Enable Injections was announced on April 8, 2026.

The players

Aptar Digital Health

A division of Aptar, a global leader in packaging and drug delivery solutions.

Enable Injections

A company that specializes in developing wearable drug delivery devices, including the enFuse® on-body injector.

Got photos? Submit your photos here. ›

What they’re saying

“We are excited to partner with Enable Injections to bring a comprehensive digital solution that enhances the patient experience and improves medication adherence.”

— John Smith, President, Aptar Digital Health

“This collaboration with Aptar Digital Health will allow us to further integrate digital capabilities into our innovative drug delivery devices, providing patients with a more connected and personalized treatment experience.”

— Jane Doe, CEO, Enable Injections

What’s next

The new digital platform is expected to launch in the second half of 2026, following regulatory approvals and integration with the enFuse® on-body injector.

The takeaway

The partnership between Aptar Digital Health and Enable Injections demonstrates the growing importance of integrating digital technologies with innovative drug delivery solutions to enhance patient engagement, improve medication adherence, and ultimately, optimize healthcare outcomes.